The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study.

Gregor John, Yannick Allanore, Pamela Polito, Silvia Piantoni, Micaela Fredi, Jérôme Avouac, Franco Franceschini, Marie-Elise Truchetet, Franco Cozzi, Paolo Airo, Carlo Chizzolini

Journal: Rheumatology (Oxford, England) 2017;56(11):1874-1883

PMID: 28977630

Abstract

OBJECTIVES

The aim of this study was to explore the association between urinary incontinence (UI) and the main clinical and serological subsets of SSc, to assess risk factors for UI and its impact on quality of life (QoL).

METHODS

UI and QoL were assessed through self-administered questionnaires in 334 patients with SSc from five European tertiary centres. Logistic regressions were performed to test the association between clinical forms, serological status and UI and to adjust for confounders. Further independent predefined SSc risk factors for UI were tested through a multivariable logistic model.

RESULTS

The prevalence of UI was 63% (95% CI: 60, 68%). lcSSc and ACAs were both significantly associated with UI even after adjusting for age, sex, disability, diabetes, BMI, caffeine consumption, dyspnoea, faecal incontinence, abnormal bowel movement, presence of overlapping rheumatological disease and pulmonary hypertension [adjusted odds ratio (OR) = 2.4; 95% CI: 1.2, 4.7]. ACA and lcSSc doubled the risk of frequent and heavy urinary leaks. Factors independently associated with UI were as follows: lcSSc (OR = 2.2; 95% CI: 1.1, 3.2), ACA (OR = 2.8; 95% CI: 1.4, 5.8), female sex (OR = 10.8; 95% CI: 2.8, 41.3), worsening of dyspnoea (OR = 6.8; 95% CI: 1.2, 36.7), higher HAQ-DI (OR = 3.2; 95% CI: 1.5, 6.7), BMI (OR = 1.1; 95% CI: 1.0, 1.1) and active finger ulceration (OR = 0.3; 95% CI: 0.1, 0.7). Patients suffering from UI had decreased QoL.

CONCLUSION

Self-reported UI is frequent in SSc and disproportionally affects the limited cutaneous form of the disease and patients positive for ACA.

TRIAL REGISTRATION

ClinicalTrials.gov, http://clinicaltrials.gov, NCT01971294.

© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: [email protected]

Address: Department of Internal Medicine, Hôpital neuchâtelois, La Chaux-de-Fonds.; Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals (HUG), Geneva, Switzerland.; Department of Rheumatology, Hôpital Cochin, Paris, France.; Department of Medicine, Rheumatology Unit, University Hospital of Padova, Padova.; Department of Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy.; Department of Rheumatology.; CNRS-UMR 5164 Immuno ConcEpT, Bordeaux University and Bordeaux Hospital, Bordeaux, France.; Immunology and Allergy, University Hospitals and School of Medicine, Geneva, Switzerland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.